A shadow market for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.
Investigational Drug Acquiring Popularity Online
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Followers are encouraged to message these profiles privately for source information, while also receiving promotional offers.
Thriving Commerce on Social Networks
Separately, a robust trade exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and claims of next-day British shipping. Sellers market the drug there before directing buyers to WhatsApp for purchases.
Learning About The Experimental Drug
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Professionals Voice Worries
However, physicians and chemists have warned that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could result in individuals injecting products of unknown origin.
Some professionals said the demand for retatrutide could be linked to the rising cost of licensed weight loss products such as Mounjaro.
Regulatory Status and Enforcement
Marketing retatrutide on social media or Telegram is illegal in the UK, as it is an unapproved medication that cannot be marketed or supplied for human use under the British medical regulations.
Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still violate pharmaceutical, advertising, and consumer laws, risking fines, legal action or imprisonment.
Platform Response and Material Elimination
According to TikTok, the service has taken down problematic content and banned related keywords and query recommendations. The organization stated it was dedicated to maintaining the service safe and investing in strengthening enforcement strategies.
Online Trading Activities
Investigations also discovered communities with up to nine thousand participants selling retatrutide using the platform's built-in search feature, which functions like a online catalog. Entering “retatrutide” instantly displays groups with thousands of users, filled with images of weight loss, glowing reviews and step-by-step instructions for mixing or injecting at residence.
After minutes of joining one community, a seller shared WhatsApp details, where most transactions take place. The seller sent an instruction manual and promised shipping within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about weight, medical conditions or previous experience.
Product Details and Pricing
Inside these communities, messages show dark colored parcels with postal service stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors usually sold at £160 for 20 milligrams. When questioned how long a injector should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Service Moderation and Security Measures
A representative for the messaging service stated it regularly moderated dangerous content on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering substances they can’t verify. Although the research behind retatrutide is sound, these digital versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.
Her staff has previously seen individuals injured by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Statement
A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject users to possibly significant health risks”.
